.Mechanisms of cytotoxicity and the cells involved Immunological reactions can lead to the destruction of cells or microorganisms and one important mechanism involves cytolytic cells whose activity is measurable in vitro.
Lymphocytes, monocytesjmacrophages, neutrophils and eosinophilscan be the effectors ofcytolytic reactions. Their activity is either independent of the presence of antibody, as in the case of cytotoxicity mediated by cytolytic T lymphocytes (CTL) and natural killer cells (NK), or dependent on the presence of antibody, as in the antibodydependent-cell-cytotoxicity (ADCC). CTL are involved in graft rejection and protection against intracellular viral infections. Cytolysis is exerted through direct cell-to-cell contact between the effectors and the targets. CTL activity is specifically directed against the immunizing antigen and has been demonstrated to be restricted by the major histocompatibility complex (MHC); that is, cytotoxic T cells and their precursors respond to foreign antigens only in association with self MHC antigens (Zinkernagel & Doherty 1979) .
NK cells are another class of cytolytic cells. They are found in peripheral blood and spleen of non-immunized humans or animals. In contrast to CTL, NK cells are nonspecific and their activity is conventionally demonstrated in vitro on long-term tumour cell lines and fetal fibroblasts (Saksela et al. 1979) . Interferon and inducers of interferon have been shown to increase this NK cytotoxicity (Santoli & Koprowski 1979) .
ADCC is mediated by different population of cells which are defined functionally. K cells, bearing receptor for the Fe fragment of IgG (FcyR cells) sometimes termed the 'third' or 'null' population, have been classically described as the mediators of ADCC (MacLennan 1972). More recently, T lymphocytes, neutrophils and eosinophils have also been found to exert cytotoxicity which is dependent on the presence of antibody on the surface of the target cell. Although the classically defined ADCC is independent of complement, recent studies have described enhancement of certain such reactions in the presence of complement. The specificity of ADCC is determined by the antibody, which by coating specific antigens on the target cell directs the effector towards the target. ADCC is not MHC restricted.
I Report of meeting of the Section of Clinical Immunology and Allergy, 9 February 1981. Accepted 21 July 1981 0141-0768/81/ I00768-03/$0 1.00/0 Professor P Perlmann (Stockholm) compared ADCC and NK activity with a special emphasis on the nature of the heterogenous effector cells and the mechanisms of target recognition. This work was done in conjunction with T Andersson, R Alsheikly, B Harfast, G Pape, H Perlmann, M Troye-Blomberg and B Wahlin. In his system of ADCC, approximately 50% of the K cells are found to bind a monoclonal antibody (OKTl) known to react with monocytes and certain 'null' cells. The remaining population involved in ADCC are FcyR + and react with OKT3, antibody which recognizes almost all peripheral blood T cells. Interestingly, in the course of the ADCC reaction, which takes several hours, some of these cells differentiate and express another T cell antigen (OKT4), found on T helper cells.
The only authentic lymphocyte receptor which triggers the cytolytic reaction is the FcyR. Other receptors, like those for complement or for IgM, appear to have a regulatory function. At suboptimal antibody concentration, the presence of C3 fragments on the target cells very strongly enhances ADCC, while C3 fragments on bystander cells inhibit it. Enhancement has been demonstrated to be due to recruitment into the reaction of additional effector cells bearing the appropriate C receptor. The results indicate that target cells carrying activated complement -and this is a common event in inflammatory tissue lesions -are highly susceptible to cell-mediated lysis in the presence of very minute amounts of specific antibodies. IgM antibodies directed against target cell antigens have a similar regulatory function to target-cell-bound C3. Highly purified IgM antibodies are not capable of inducing ADCC; however, such antibodies may strongly enhance IgG dependent ADCC provided IgM and IgG react with the same target cells. On the other hand, an excess of IgM may be inhibitory. The effector cells mediating IgM dependent regulation are a subset ofT cells having distinct receptors for both IgG and IgM. The IgM dependent regulation of ADCC is believed to be important in early phases of an immune response when IgM antibodies predominate.
NK cells are large granular lymphocytes which, like K cells, are FcyR +. A large proportion of them also have receptors for sheep erythrocytes. In contrast to K cells, NK cells still display cytotoxic activity after irreversible loss of the Fe receptor by exposure to antibody-antigen complexes. When lymphocytes from healthy donors are added to virus-infected target cells, their natural cytotoxicity is strongly enhanced. The same results are obtained when the lymphocytes are pretreated for a few minutes with live or UVinactivated virions. The virus product which is responsible for this increased cytotoxicity is the peplomer carrying the haemagglutinin and neuraminidase activity of the virus while the glycoprotein carrying fusion factor activity is inactive in this respect. While the haemagglutinin may improve effector cell-target contacts, and thereby contribute to the expression of cytotoxicity, aggregation by itself is not sufficient to induce this cytotoxicity which is not ADCC reaction. Neither does it reflect previous immunization of the lymphocytes since virus treated cord blood lymphocytes are as cytotoxic as those from adult donors. This virus-induced cytotoxicity may be displayed by both FcyR + and FCyR -lymphocytes, including T cells. Which effector cells predominafe in a given system depends on the nature of the target cells. Thus, . while human target cells are primarily killed by FcyR -cells, target cells of animal origin are primarily killed by FcyR + cells. Such data suggest that the virus-dependent enhancement of lymphocyte cytotoxicity probably includes both a natural cytotoxicity of an unknown specificity and cytotoxicity involving polyclonal activation of cytolytic T cells.
The natural cytotoxicity of human lymphocytes is highly heterogeneous reflecting a variety of both antibody-dependent and antibody-independent cytolytic mechanisms displayed by several types of effector cells.
Dr A Butterworth (Cambridge) reviewed the recent studies on in vitro cytotoxicity of the young larvae (schistosomula) of Schistosoma mansoni by eosinophils in the presence of antibody, complement or both. He demonstrated the necessity of degranulation of the eosinophils upon contact with the antibody-coated schistosomula for selective damage to occur, the released granule contents promoting both adherence of the effector cell and directly damaging the parasite (Vadas et al. 1979) . The ability of eosinophils to damage schistosomula appears to be an example of a more generalized interaction of eosinophils with a variety of helminths, including both trematodes' and nematodes. Various ligands can mediate this interaction, including IgE as well as IgG antibodies, and complement. Complement may be fixed either by the classical or by the alternative pathways. Eosinophils vary in their capacity to kill schistosomula, and killing. activity may be markedly enhanced in two situations: (I) after interaction with mast cell mediators (Anwar et al. 1980) : such an enhancement, occurring at sites of immediate hypersensitivity reactions to larvae may promote the local destruction of helminths at the site of tissue invasion; and (2) in conditions of peripheral blood eosinophilia (David et al. 1980) : in this case the reason for the enhanced killing activity is not known but may reflect a functional alteration resembling macrophage 'activation'.
These findings, together with the known associations between helminth infections, eosinophilia and IgE responses, suggest that the eosinophil may have an important role to play in the host's defences against helminth infection. Considerable evidence for such a role is now emerging from studies in vivo in experimental animals.
Professor I C M MacLennan (Birmingham) compared the mechanism of lymphoid (CTL and K cell) and myeloid (macrophage and neutrophil) cell-mediated killing. By the study of some biochemical requirements the mechanisms of T and K cell-mediated cytolysis have been divided into three phases: (I) A short recognition phase occurring at room temperature, independent of the presence of Ca ++/Mg" + divalent cations and inhibitable by cytochalasin A (microfilament inhibitor).
(2) A lethal-hit phase which is dependent on availability of divalent cations and requires Dglucose for optimal expression.
(3) A prolonged target cell disintegration phase which can last from many minutes to a few hours. This phase is independent of Ca ++/Mg+ + and effector cells are not essential.
With the exception that K cells bind firmly to their targets, in comparison to the relatively weak binding between CTL and their targets, the basic mechanisms of killing appear to be the same for both effectors.
The biochemical requirements for macrophage and neutrophil killing are' clearly different from the requirements for T and K cell killing. In contrast to the lymphoid killing, myeloid killing is not inhibited by 2-deoxy-D-glucose (competitive inhibitor ofD-glucose) or cytochalasin A and does not require the presence of divalent cations at any phase. The mechanisms of cytolysis can be divided into two main types: (I) activation and release of hydrolytic enzymes from lysosomes; (2) the production of toxic oxygen products associated with increased pentose cyclic activity. In conclusion, lymphoid cell killing and myeloid cell killing appear to involve quite distinct mechanisms.
The last two speakers reviewed recent work on virus-induced cytolytic T lymphocytes. Dr A J McMichael (Oxford) dealt with studies using influenza virus in humans (McMichael 1980) and Dr H R MacDonald (Ludwig Institute for Cancer Research, Lausanne) described studies using the murine-sarcoma-virus induced tumours in mice.
Dr McMichael reported that when human peripheral blood lymphocytes are incubated for three or more days with autologous lymphocytes that have been previously infected with influenza A virus in vitro, cytotoxic T lymphocytes are generated. These CTL show specificity for the influenza virus type, A or B, but cannot distinguish between the different influenza A virus subtypes on the surface of infected cells. These T cells only lyse infected cells that share one or more .of their HLA-A or B locus antigens. It follows that precursors of cytotoxic T cells respond to virus plus HLA antigen and that the CTL must see the same combination on target cells to activate the lytic process (McMichael 1978) .Experiments have shown that recognition of HLA is exquisitely specific; in many instances activated cytotoxic T cells have failed to lyse target cells that appear to share (serologically-defined) HLA antigens. This can be due to serologically silent subgroups of HLA antigens, but examples of non-recognition of target cells have also been described in studies using donors who must carry identical HLA antigens. The results indicate that only one or two HLA-A or B antigens, out of four in a heterozygous individual, may be chosen for a T cell response to a specific virus. It is possible that there may be genetic basis for these unexplained occurrences. HLA antigens are able to affect the quality of the T cell response to influenza virus infection (Shaw & Biddison 1979) . Preliminary studies at the Common Cold Research Centre, in collaboration with Dr Tyrell and Dr Beare, have indicated that volunteers with an increased number of inducible influenza specific cytotoxic T cells, on admission are resistant to infection with the influenza virus.
Dr MacDonald described experiments utilizing cloning of cytolytic T lymphocytes and their precursors, a process which allows a very precise and particular study of CTL restriction. A sensitive mixed leukocyte microculture technique (micro-MLC) has been developed to analyse the progeny of individual cytolytic T lymphocyte precursor cells (CTL-P). Optimal sensitivity of the system was found to be dependent upon the addition of soluble growth-promoting factors present in the supernatant of secondary mixed leucocyte cultures (Ryser & MacDonald 1979) . By applying Poisson statistics to large numbers of micro MLC, minimal estimates of the frequency of CTL-P directed against alloantigens and oncorna-virus-associated antigens in the lymphoid tissues of normal and immunized mice have been obtained ). In addition, by simultaneously assaying aliquots of individuals' microcultures for cytotoxicity against several target cells, it has been possible to investigate the specificity of CTL which are theoretically the progeny of individual CTL-P. An extension of this model system to allow the direct cloning of CTL has been made possible by the observation that the frequency of operation defined CTL-P increases by 50-100 fold (to a maximum value of 20-50%) after specific priming in vitro (Maryanski et al. 1980) . Clones isolated from such primed populations under limiting dilution conditions have been propagated for extended periods of time (up to one year) without apparent loss of cytolytic activity or antigenic specificity. Furthermore, subcloning of such cytolytic clones has shown that most (if not all) of the daughter subclones are stable with respect to their cytolytic phenotypes . A detailed analysis of a number of CTL clones reactive with murine sarcoma virus (MSV) associated' antigens has been performed (Weiss et al. 1980) . The majority of such clones were found to lyse only syngeneic, virus-infected target cells. By using appropriate monoclonal antibodies to inhibit cytolysis, this lysis was further shown to be restricted, in the case of C57BL/6 mice, to the H-2Db gene product. A small but significant fraction of clones, however, was found to lyse allogeneic virus-infected target cells or uninfected allogeneic target cells. These studies indicate that the technology of cell cloning will be of considerable value in establishing the specificity repertoire of CTL.
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